Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
APYX

APYX - Apyx Medical Corp Stock Price, Fair Value and News

$3.98-0.21 (-5.01%)
Market Closed

10/100

APYX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

10/100

APYX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$3.18

Target 3M

$3.57

Target 6M

$3.37

APYX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

APYX Price Action

Last 7 days

-0.2%

Last 30 days

13.7%

Last 90 days

34.9%

Trailing 12 Months

176.4%

APYX RSI Chart

APYX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

APYX Valuation

Market Cap

152.2M

Price/Earnings (Trailing)

-10.5

Price/Sales (Trailing)

3.18

EV/EBITDA

-14.05

Price/Free Cashflow

-16.11

APYX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$3.18

Target 3M

$3.57

Target 6M

$3.37

APYX Fundamentals

APYX Revenue

Revenue (TTM)

47.9M

Rev. Growth (Yr)

12.1%

Rev. Growth (Qtr)

13.22%

APYX Earnings

Earnings (TTM)

-14.5M

Earnings Growth (Yr)

57.81%

Earnings Growth (Qtr)

46.92%

APYX Profitability

EBT Margin

-29.77%

Return on Equity

-247.95%

Return on Assets

-25.28%

Free Cashflow Yield

-6.21%

APYX Investor Care

Shares Dilution (1Y)

10.39%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202547.3M46.5M47.9M0
202450.5M49.0M48.5M48.1M
202344.2M47.4M50.3M52.3M
202252.4M51.4M48.7M44.5M
202131.4M38.3M43.2M48.5M
202027.6M25.3M24.6M27.7M
201918.8M21.8M25.7M28.2M
201812.0M13.4M14.4M16.6M
201730.5M23.5M16.1M10.2M
201631.2M33.2M35.4M36.6M
201527.3M27.7M28.7M29.5M
20148.0M14.4M20.8M27.7M
201326.6M25.2M13.4M1.6M
201226.0M26.6M27.0M27.7M
201124.8M25.7M25.5M25.4M
201000024.2M
Get all data in R, Python etc through our Historical Stock Data APIs

About Apyx Medical Corp

APYX
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and laparoscopic surgical procedures. The company's Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also offers hand pieces for open and laparoscopic procedures, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
 CEO
 WEBSITEapyxmedical.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES276

Apyx Medical Corp Frequently Asked Questions

APYX is the stock ticker symbol of Apyx Medical Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Apyx Medical Corp is 152.2 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check APYX's fair value in chart for subscribers.

The fair value guage provides a quick view whether APYX is over valued or under valued. Whether Apyx Medical Corp is cheap or expensive depends on the assumptions which impact Apyx Medical Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for APYX.

As of Wed Jan 28 2026, APYX's PE ratio (Price to Earnings) is -10.5 and Price to Sales (PS) ratio is 3.18. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. APYX PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Apyx Medical Corp has provided 0.019 (multiply by 100 for percentage) rate of return.